Paricalcitol

FDA Approved: * September 27, 2013
Pharm Company: * TEVA PHARMS
Category: Thyroid

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Paricalcitol Overview

Paricalcitol (chemically it is 19-nor-1,25-(OH)2-vitamin D2. Marketed by Abbott Laboratories under the trade name Zemplar) is a drug used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic kidney failure. It is an analog of 1,25-dihydroxyergocalciferol, the active form of vitamin D2 (ergocalciferol). It was patented in 1989 and approved for medical use in 1998.[2] Contents 1 Medical uses 2 Ad...

Read more Paricalcitol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Paricalcitol

Recent Paricalcitol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Paricalcitol
  • Capsule: 1mcg, 1ugm, 2mcg, 2ugm, 4mcg, 4ugm
  • Injection: 0.002mg/ml, 0.005mg/ml, 0.01mg/2ml (0.005mg/ml), 0.04mcg/kg To 0.1mcg/kg, 10mcg/2ml, 10mcg/ml, 2mcg/ml, 5mcg/ml
  • Solution: 0.002mg/ml (0.002mg/ml), 0.005mg/ml (0.005mg/ml), 0.01mg/2ml (0.005mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Paricalcitol: (77 results)

Showing the first 20, Sorted by National Drug Code
  • 0093-7656 Paricalcitol 1 Mcg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7657 Paricalcitol 2 Mcg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0093-7658 Paricalcitol 4 Mcg Oral Capsule by Teva Pharmaceuticals USA Inc
  • 0143-9596 Paricalcitol 5 ug/ml Intravenous Injection by West-ward Pharmaceutical Corp
  • 0143-9624 Paricalcitol 5 ug/ml Intravenous Injection by West-ward Pharmaceutical Corp
  • 0143-9625 Paricalcitol 2 ug/ml Intravenous Injection by West-ward Pharmaceutical Corp
  • 0409-1007 Paricalcitol 2 ug/ml Intravenous Injection, Solution by Hospira, Inc.
  • 0409-1008 Paricalcitol 5 ug/ml Intravenous Injection, Solution by Hospira, Inc.
  • 10888-5001 Paricalcitol 1 ug/1 Oral Capsule, Liquid Filled by Banner Pharmacaps
  • 10888-5002 Paricalcitol 2 ug/1 Oral Capsule, Liquid Filled by Banner Pharmacaps
  • 10888-5003 Paricalcitol 4 ug/1 Oral Capsule, Liquid Filled by Banner Pharmacaps
  • 16729-310 Paricalcitol 2 ug/ml Intravenous Injection, Solution by Accord Healthcare, Inc.
  • 16729-311 Paricalcitol 5 ug/ml Intravenous Injection, Solution by Accord Healthcare, Inc.
  • 17478-033 Paricalcitol 5 ug/ml Intravenous Injection, Solution by Akorn, Inc.
  • 25000-012 Paricalcitol 1 ug/1 Oral Capsule, Liquid Filled by Marksans Pharma Limited
  • 25000-014 Paricalcitol 2 ug/1 Oral Capsule, Liquid Filled by Marksans Pharma Limited
  • 25000-017 Paricalcitol 4 ug/1 Oral Capsule, Liquid Filled by Marksans Pharma Limited
  • 40051-612 Paricalcitol 1 ug/1 Oral Capsule by Lotus Pharmaceutical Co., Ltd. Nantou Plant
  • 40051-613 Paricalcitol 2 ug/1 Oral Capsule by Lotus Pharmaceutical Co., Ltd. Nantou Plant
  • 40051-614 Paricalcitol 4 ug/1 Oral Capsule by Lotus Pharmaceutical Co., Ltd. Nantou Plant
  • 57 more results ...

Other drugs which contain Paricalcitol or a similar ingredient: (1 result)